Psychedelic Drugs Market is growing with a CAGR of 13.3% and is expected to reach USD 8,020.01 million by 2029

NEW YORK, UNITED STATES, UNITED STATES OF AMERICA, May 30, 2022 /EINPresswire.com/ -- Global psychedelic drugs market is expected to gain market growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses that the market is growing with a CAGR of 13.3% in the forecast period of 2022 to 2029 and is expected to reach USD 8,020.01 million by 2029 from USD 2,992.51 million in 2021. Rising prevalence of mental depression and anxiety and availability of off label drugs are the major drivers which propelled the demand of the market in the forecast period.

Global Psychedelic Drugs Market report is highly beneficial in planning of production, product launches, costing, inventory, purchasing, and marketing strategies. This market report provides categorization by companies, region, type and end-use industry. For better decisions, more revenue generation, and profitable business, this business research report is the key. The marketing report helps to measure and optimize each step in the lifecycle of industrial process including engagement, acquisition, retention, and monetization. A market analysis document deals with plentiful aspects of the A industry. Valuable and actionable market insights covered in this report are always important when it comes to create sustainable and profitable business strategies.

A wide-ranging market research has been conducted in the world class Global Psychedelic Drugs Market report which puts a light on the challenges, market structures, opportunities, driving forces, scope, and competitive landscape for the business. To give knowledge about the industry insights so that nothing gets missed out, this is the valuable market report. The report displays the systematic investigation of current scenario of the market, which covers several market dynamics. Nowadays, businesses are highly relying on the different segments covered in the market research report which presents better insights to drive the business into right direction.  

Get a Sample PDF of the Global Psychedelic Drugs Market report -  https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-psychedelic-drugs-market

Global Psychedelic Drugs Market Scenario                            

According to Data Bridge Market Research, the market for psychedelic drugs in North America region has the highest market share in psychedelic drugs market. Market leader is Jazz Pharmaceutical, Inc. which accounts an estimated market share of approximately 70%. The company has gained outstanding sale through providing products that are used in psychedelic treatment.

Psychedelic drugs involve various types of chemical substances including LSD and chemical extracted from plants. Psychedelic drugs have the ability to change or enhance the sensory perceptions, thought processes, energy levels and have also been reported to facilitate spiritual experiences. Psychedelic drugs can be categorized into empathogens and dissociative drugs (such as PCP) and serotonergic (classic hallucinogens) such as LSD. Both the types of psychedelic drugs can cause hallucinations and feeling of sensation, moreover, dissociative drugs can make a person to fell out of control from their body or environment and makes them feel disconnected. Based on the source, psychedelic drugs have been categorized under natural and synthetic types. These drugs have wide applications in the treatment of major depressive disorder, post-traumatic stress disorder, panic disorder, treatment-resistant depression and opiate addiction among others. Psychedelic drugs are also known by several other names such as LSD (lysergic acid derivative) which are also known as blotter, dots, sugar, acid, trips and window pane, ketamine are also known as vitamin K, bump, green, K/special K, purple and super acid, PCP are also known as angel/angel dust, boat/love boat, peace, killer weed, super grass and ozone. 

The increasing prevalence of depression and mental disorders worldwide as the psychedelic drugs have repetitively proven for its high rates of effectiveness is expected to act as driver for the growth of the market. The high cost of treatment is expected to act as challenge for the growth of the market. Further, rising awareness towards mental health by various non-profit, non-governments, government, national, international organizations is expected to act as opportunity for the growth of the market. However, the side effects associated may expected to challenge the market growth. 

The Global psychedelic drugs report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

Global Psychedelic Drugs Market Development

In July 2020, Jazz Pharmaceuticals, Inc. announced that it has received FDA approval for its Xywav oral solution for the treatment of excessive daytime sleepiness. The product is an oxybate product with unique composition of cations resulting in 92% less sodium. This has helped the company to increase its product portfolio.


The global psychedelic drugs market is segmented into five regions, North America, Europe, Asia-Pacific, South America and Middle East and Africa. The regions are further segmented into major countries such as the U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, Russia, Poland, Switzerland, Netherlands, Hungary, Austria, Norway, Ireland, Belgium, Lithuania, Rest of Europe, India, Australia, South Korea, Singapore, Malaysia, Saudi Arabia, Israel, Egypt, U.A.E, South Africa, Rest of Middle East and Africa, Brazil, Argentina & Rest of South America. All country-based analysis of global psychedelic drugs market is further analyzed based on further segmentation. 

Global psychedelic drugs market, by source (synthetic, natural), type (empathogens, dissociatives, others), drugs (child gamma-hydroxybutyric acid, ketamine, psilocybin, others), application (narcolepsy, treatment resistant depression, major depressive disorder, opiate addiction, post-traumatic stress disorder, others) route of administration (oral, inhalation, injectables) end user (hospitals, specialty clinics, homecare and others), distribution channel (hospital pharmacy, retail pharmacy, online pharmacy), By Geography (North America, Europe, Asia-Pacific, South America, Middle East & Africa)- Industry Trends and Forecast to 2029.

Inquire Before Buying of Global Psychedelic Drugs Market Click Here:  https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-psychedelic-drugs-market 

Key Market Competitors Covered in the Report 

Jazz Pharmaceuticals, Inc.

Janssen Pharmaceuticals, Inc. (A Subsidiary of Johnson & Johnson Services, Inc.)

Pfizer Inc.

Verrian

Avadel

Celon Pharma S.A.

COMPAS

Hoffmann-La Roche Ltd

Hikma Pharmaceuticals PLC

NeuroRx, Inc.

PharmaTher Inc.

usonainstitute.org

Mind Medicine, Inc.

Cybin Corp.

GABA Therapeutics, Inc.

EmpathBio

DemeRx

Global Psychedelic Drugs Market Scope and Market Size

Global psychedelic drugs market is segmented into seven notable segments which are by source, type, drugs, application, route of administration, end user & distribution channel.

 On the basis of source, the global psychedelic drugs market is segmented into synthetic and natural. In 2022, the synthetic segment is expected to dominate the global psychedelic drugs market as most of the products are made from chemicals that are man-made with very few products (such as psilocybin) made from natural ingredients.

On the basis of type, the global psychedelic drugs market is segmented into empathogens, dissociatives, and others. In 2022, the empathogens segment is expected to dominate the global psychedelic drugs market as it produce experiences of emotional communion, oneness, relatedness and used for treatment of cataplexy, narcolepsy and related disorders.

On the basis of drugs, the global psychedelic drugs market is segmented into gamma-hydroxybutyric acid, ketamine, psilocybin and others. In 2022, the gamma-hydroxybutyric acid segment is expected to dominate the global psychedelic drugs market as xyrem whose active ingredient is gamma-hydroxybutyric acid, from Jazz Pharmaceutical is one of the oldest available psychedelic drugs available in the market holding a major share and belongs to the drug class.

On the basis of application, the global psychedelic drugs market is segmented into narcolepsy, treatment resistant depression major depressive disorder, opiate addiction, post-traumatic stress disorder and others. In 2022, the narcolepsy segment is expected to dominate the global psychedelic drugs market as large number of population suffers from narcolepsy.

On the basis of route of administration, the global psychedelic drugs market is segmented into oral, inhalation and injectable. In 2022, the oral segment is expected to dominate the global psychedelic drugs market as it is preferred over the various other administration routes of drug delivery. It offers several advantages including safety, easier patient compliance and pain/inconvenience avoidance.

On the basis of end user, the global psychedelic drugs market is segmented into hospitals, specialty clinics, homecare and others. In 2022, the hospitals segment is expected to dominate the global psychedelic drugs market due to the high patient load and most of the drugs are given under doctor’s supervision. Due to this reason, hospitals segment dominates the psychedelic drugs market.

On the basis of distribution channel, the global psychedelic drugs market is segmented into hospitals pharmacy, retail pharmacy and online pharmacy. In 2022, the hospitals pharmacy segment is expected to dominate the global psychedelic drugs market as it holds the largest market share as more number of patients are treated in hospitals and the demand for medicines in hospital pharmacy increases.

To Gain More Insights into the Market Analysis, Browse Summary of the Research Report@ https://www.databridgemarketresearch.com/reports/global-psychedelic-drugs-market

Global Psychedelic Drugs Market Country Level Analysis

Global psychedelic drugs market is analysed and market size information is provided on basis of seven notable segments which are by source, type, drugs, application, route of administration, end user & distribution channel. 

Countries included in global psychedelic drugs market are U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, Russia, Poland, Switzerland, Netherlands, Hungary, Austria, Norway, Ireland, Belgium, Lithuania, Rest of Europe, India, Australia, South Korea, Singapore, Malaysia, Saudi Arabia, Israel, Egypt, U.A.E, South Africa, Rest of Middle East and Africa, Brazil, Argentina & Rest of South America. 

North America is expected to grow with the fastest CAGR in the forecasted periods due to the advancements in healthcare sector, rising R&D, and increasing awareness among people. Europe is expected to grow due to increasing prevalence of mental disorders and effectiveness of psychedelic to treat such disorders. Asia-Pacific is expected to grow due to the growing acceptance of psychedelic to treat depression. 

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

 Table of Content Global Psychedelic Drugs Market:

1 INTRODUCTION 

2 MARKET SEGMENTATION 

3 EXECUTIVE SUMMARY 

4 PREMIUM INSIGHTS 

5 REGULATORY FRAMEWORK: GLOBAL PSYCHEDELIC DRUGS MARKET 

6 MARKET OVERVIEW 

7 COVID-19 IMPACT ON GLOBAL PSYCHEDELIC DRUGS MARKET 

8 GLOBAL PSYCHEDELIC DRUGS MARKET, BY TYPE 

9 GLOBAL PSYCHEDELIC DRUGS MARKET, BY SOURCE 

10 GLOBAL PSYCHEDELIC DRUGS MARKET, BY DRUGS 

11 GLOBAL PSYCHEDELIC DRUGS MARKET, BY APPLICATION 

12 GLOBAL PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION 

13 GLOBAL PSYCHEDELIC DRUGS MARKET, BY END USER 

14 GLOBAL PSYCHEDELIC DRUGS MARKET, BY DISTRIBUTION CHANNEL 

15 GLOBAL PSYCHEDELIC DRUGS MARKET, BY REGION 

16 GLOBAL PSYCHEDELIC DRUGS MARKET: COMPANY LANDSCAPE 

17 SWOT ANALYSIS 

18 COMPANY PROFILE 

19 QUESTIONNAIRE 

20 RELATED REPORTS

Continued... 

Table of Content of Browse the complete table of contents Psychedelic Drugs Market -  https://www.databridgemarketresearch.com/toc/?dbmr=global-psychedelic-drugs-market

List of Figures:

FIGURE 1 GLOBAL PSYCHEDELIC DRUGS MARKET: SEGMENTATION 

FIGURE 2 GLOBAL PSYCHEDELIC DRUGS MARKET : DATA TRIANGULATION 

FIGURE 3 GLOBAL PSYCHEDELIC DRUGS MARKET: DROC ANALYSIS 

FIGURE 4 GLOBAL PSYCHEDELIC DRUGS MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS 

FIGURE 5 GLOBAL PSYCHEDELIC DRUGS MARKET: COMPANY RESEARCH ANALYSIS 

FIGURE 6 GLOBAL PSYCHEDELIC DRUGS MARKET: MULTIVARIATE MODELLING 

FIGURE 7 GLOBAL PSYCHEDELIC DRUGS MARKET: INTERVIEW DEMOGRAPHICS 

FIGURE 8 GLOBAL PSYCHEDELIC DRUGS MARKET: DBMR MARKET POSITION GRID 

FIGURE 9 GLOBAL PSYCHEDELIC DRUGS MARKET: MARKET APPLICATION COVERAGE GRID 

FIGURE 10 GLOBAL PSYCHEDELIC DRUGS MARKET: VENDOR SHARE ANALYSIS

Continued... 

Related Reports:

U.S. Psychedelic Drugs Market, By Source (Synthetic, Natural), Type (Empathogens, Dissociatives, Others), Drugs (Gamma-Hydroxybutyric Acid, Ketamine, Psilocybin, Others), Application (Narcolepsy, Treatment Resistant Depression, Major Depressive Disorder, Opiate Addiction, Post-Traumatic Stress Disorder, Others), Route of Administration (Oral, Inhalation, Injectable), End-User (Hospitals, Specialty Clinics, Homecare, Others), Distribution Channel (Hospitals Pharmacy, Retail Pharmacy, Online Pharmacy) – Industry Trends and Forecast to 2029.https://www.databridgemarketresearch.com/reports/us-psychedelic-drugs-market

North America Psychedelic Drugs Market, By Source (Synthetic & Natural), Type (Empathogens, Dissociatives & Others), Drugs (Gamma-Hydroxybutyric Acid, Ketamine, Psilocybin & Others), Application (Narcolepsy, Treatment Resistant Depression, Major Depressive Disorder, Opiate Addiction, Post-Traumatic Stress Disorder & Others), Route of Administration (Oral, Inhalation & Injectable), End User (Hospitals, Specialty Clinics, Homecare & Others), Distribution Channel (Hospitals Pharmacy, Retail Pharmacy & Online Pharmacy) Country (U.S., Canada, Mexico). Market Trends and Forecast to 2029.https://www.databridgemarketresearch.com/reports/north-america-psychedelic-drugs-market

 Middle East and Africa Psychedelic Drugs market, By Source (Synthetic & Natural), Type (Empathogens, Dissociatives & Others), Drugs (Gamma-Hydroxybutyric Acid, Ketamine, Psilocybin & Others), Application (Narcolepsy, Treatment Resistant Depression, Major Depressive Disorder, Opiate Addiction, Post-Traumatic Stress Disorder & Others), Route of Administration (Oral, Inhalation & Injectable), End User (Hospitals, Specialty Clinics, Homecare & Others), Distribution Channel (Hospitals Pharmacy, Retail Pharmacy & Online Pharmacy), Country (Saudi Arabia, Israel, Egypt, U.A.E, South Africa and Rest of Middle East and Africa). Market Trends and Forecast to 2029.https://www.databridgemarketresearch.com/reports/middle-east-and-africa-psychedelic-drugs-market

 Asia-Pacific Psychedelic Drugs Market, By Source (Synthetic & Natural), Type (Empathogens, Dissociatives & Others), Drugs (Gamma-Hydroxybutyric Acid, Ketamine, Psilocybin & Others), Application (Narcolepsy, Treatment Resistant Depression, Major Depressive Disorder, Opiate Addiction, Post-Traumatic Stress Disorder & Others), Route of Administration (Oral, Inhalation & Injectable), End User (Hospitals, Specialty Clinics, Homecare & Others), Distribution Channel (Hospitals Pharmacy, Retail Pharmacy & Online Pharmacy), Country (India, Australia, South Korea, Singapore, Malaysia) - Market Trends and Forecast to 2029.https://www.databridgemarketresearch.com/reports/asia-pacific-psychedelic-drugs-market

Europe Psychedelic Drugs Market, By Source (Synthetic & Natural), Type (Empathogens, Dissociatives & Others), Drugs (Gamma-Hydroxybutyric Acid, Ketamine, Psilocybin & Others), Application (Narcolepsy, Treatment Resistant Depression, Major Depressive Disorder, Opiate Addiction, Post-Traumatic Stress Disorder & Others), Route of Administration (Oral, Inhalation & Injectable), End User (Hospitals, Specialty Clinics, Homecare & Others), Distribution Channel (Hospitals Pharmacy, Retail Pharmacy & Online Pharmacy)- Industry Trends and Forecast to 2029.https://www.databridgemarketresearch.com/reports/europe-psychedelic-drugs-market

 About Us: 

Data Bridge Market Research has presented itself as an unconventional, neoteric market research and consulting company with an unprecedented level of resilience and integrated approaches. We are committed to finding the best market opportunities and promoting effective information for your business to thrive in the market. Data Bridge Market Research provides appropriate solutions to complex business challenges and initiates an effortless decision-making process.

Sopan Gedam
Data Bridge Market Research
+1 888-387-2818
email us here

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.